NNM Securities

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma

BSE1486.903.15 (+0.21 %)

PREV CLOSE ( ) 1483.75

OPEN PRICE ( ) 1483.70

BID PRICE (QTY) 1486.40 (31)

OFFER PRICE (QTY) 1487.00 (1)

VOLUME 36385

TODAY'S LOW / HIGH ( )1479.50 1503.00

52 WK LOW / HIGH ( )922.55 1638.7

NSE1485.050.4 (+0.03 %)

PREV CLOSE( ) 1484.65

OPEN PRICE ( ) 1484.65

BID PRICE (QTY) 1485.05 (59)

OFFER PRICE (QTY) 1485.40 (108)

VOLUME 4359515

TODAY'S LOW / HIGH( ) 1479.35 1503.00

52 WK LOW / HIGH ( )922.45 1638.85

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-03 1993

Management Info

- Chairman Dilip S Shanghvi - Managing Director

Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE, MCX

NEWS

12Apr USFDA issues OAI status to Sun Pharmac
US Food and Drug Administration (USFDA) has issued Official Action Indic..

28Mar Clarification sought from Sun Pharmac
The Exchange has sought clarification from Sun Pharmaceutical Industries..

23Mar Sun Pharmaceutical Industries informs
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

19Mar Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed that it enclosed a copy of th..

16Mar Sun Pharmaceutical Industries informs
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclo..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	7213.1	16907.2
Gross Profit	7514.7	17410.5
Operating Profit	14358	67518.9
Net Sales	50737.5	208121.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2623.70 (5.86%)	M.Cap (Rs. in Cr)1601.53
Glaxosmithkline Phar (BSE) 2077.00 (6.92%)	M.Cap (Rs. in Cr)35100.93
TTK Healthcare (BSE) 1617.65 (7.52%)	M.Cap (Rs. in Cr)2243.76
Torrent Pharma (BSE) 2688.20 (1.97%)	M.Cap (Rs. in Cr)91079.05
Cipla (BSE) 1398.00 (3.73%)	M.Cap (Rs. in Cr)112841.52

Shareholding Pattern

	PROMOTERS	54.48%
	MUTUAL FUNDS/UTI	12.21%
	NON-INSTITUTION	8.97%
	FI/BANKS/INSURANCE	5.12%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
ICICI Pru Nifty Pha...	26.82
Nippon India Nifty ...	26.80
ICICI Pru Nifty Hea...	23.50
Axis NIFTY Healthcare ETF	23.48
Aditya Birla SL Nif...	23.46
Motilal Oswal S&P B...	17.56
Kotak Healthcare Fu...	17.34

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

SUN PHARMACEUTICAL INDUSTRIES LTD.

Filing compliant on SCORES – Easy & quick